ACI American Conference Institute Business Information in a Global Context

Latest Insights into: • FCPA Enforcement under the Trump Administration • ISO 37001 • Technology Innovations

June 27-28, 2017 | Park Lane Hotel | New York, NY


11th Advanced Forum on FCPA & ANTI-CORRUPTION for the Life Sciences Industry

Conference Co-Chairs:

Special Speaker from the U.S. Department of Justice Sandra Moser Acting Chief U.S. Department of Justice, Criminal Division, Fraud Section

Leah Lorber Assistant General Counsel

Daniel J. Moynihan Global Compliance Officer - Life Science MilliporeSigma, A business of Merck KGaA

GlaxoSmithKline (Washington, DC)

New 2017 Expert Sessions

✓ ✓ ISO 37001 and Other Compliance Certifications: Weighing Pros and Cons in the Life Sciences Context ✓ ✓ Section 13 of the FCPA: Why “Gatekeepers” of the Internal Controls Provisions are under Increased Scrutiny ✓ ✓ GDPR and Privacy Legislation: How Life Sciences Companies Should Prepare ✓ ✓ How to Minimize the Most Common Risks with PODs ✓ ✓ Technology Innovations for Compliance Programs that Will Make your Employees Want to Participate

✓ ✓ Prosecutor Alumni Panel: How Life Sciences Companies Should Determine Where and How Much to Invest in Anti-Corruption Compliance ✓ ✓ FCPA Enforcement Think Tank: Four Months into the Trump Administration ✓ ✓ Exclusive Deep Dive into Corporate Culture and Restoration of Confidence Post-Scandal ✓ ✓ M&A and JV: Due Diligence and Integration of Compliance Programs

Interactive Workshops:

A China 2.0: Revised Legislation, Commercial Bribery, Third Party Risks and Pitfalls with the Media

B Event Sponsorship, Charitable Donations, Gifts, Travel & Entertainment, and Hospitality Pitfalls in the Life Sciences Industry


Governance. Risk. Compliance.


Register Before | April 21, 2017 | and save! FCPAconference.com/Pharma | 1-888-224-2480

a C5 Group Company Business Information in a Global Context

Made with FlippingBook - Online catalogs